
Crinetics Pharmaceuticals Hits Day Low of $38.81 Amid Price Pressure
2025-11-10 17:53:56Crinetics Pharmaceuticals, Inc. has faced significant challenges, with a notable decline in stock performance and ongoing financial difficulties, including 25 consecutive quarters of negative results. Despite a substantial increase over the past three years, the company's recent trajectory and year-to-date performance raise concerns about its profitability and market position.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






